Are you living with Crohn's Disease?
We are looking for people with Crohn's Disease to participate in a study to determine the safety and effictiveness of a new study medication, guselkumab.
Guselkumab is made in the laboratory and is a fully human monoclonal antibody. An antibody is something that targets and kills foreign objects in the body - in this case, small proteins that are released by cells and affect the behaviour of other cells. This antibody, guselkumab, recognizes and blocks a specific small protein, IL-23, which is important in immune and inflammatory processes.
Anticipated date that enrolment will close: 31 December 2022
Who can take part
Inclusion
- Crohn’s Disease for at least 3 months
Exclusion
- Symptomatic stricture
- Current abscess
- Bowel resection in last 6 months
- Draining Stoma or Ostomy
What is involved for you
Medical History, Physical Exam, Electrocardiogram (ECG), Weight, Height, Blood Pressure, Pulse, Heart Rate, Health Questionnaires, Blood Samples, Urine Test, Colonoscopy with biopsy collection, Stool Tests